342 related articles for article (PubMed ID: 21041724)
1. Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12.
Forthal DN; Gach JS; Landucci G; Jez J; Strasser R; Kunert R; Steinkellner H
J Immunol; 2010 Dec; 185(11):6876-82. PubMed ID: 21041724
[TBL] [Abstract][Full Text] [Related]
2. Significant impact of single N-glycan residues on the biological activity of Fc-based antibody-like fragments.
Jez J; Antes B; Castilho A; Kainer M; Wiederkum S; Grass J; Rüker F; Woisetschläger M; Steinkellner H
J Biol Chem; 2012 Jul; 287(29):24313-9. PubMed ID: 22589538
[TBL] [Abstract][Full Text] [Related]
3. Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function.
Chung AW; Crispin M; Pritchard L; Robinson H; Gorny MK; Yu X; Bailey-Kellogg C; Ackerman ME; Scanlan C; Zolla-Pazner S; Alter G
AIDS; 2014 Nov; 28(17):2523-30. PubMed ID: 25160934
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of Antibody-Dependent Cellular Cytotoxicity and Phagocytosis in Anti-HIV-1 Human-Bovine Chimeric Broadly Neutralizing Antibodies.
Edwards JM; Heydarchi B; Khoury G; Salazar-Quiroz NA; Gonelli CA; Wines B; Hogarth PM; Kristensen AB; Parsons MS; Purcell DFJ
J Virol; 2021 Jun; 95(13):e0021921. PubMed ID: 33853957
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques.
Moog C; Dereuddre-Bosquet N; Teillaud JL; Biedma ME; Holl V; Van Ham G; Heyndrickx L; Van Dorsselaer A; Katinger D; Vcelar B; Zolla-Pazner S; Mangeot I; Kelly C; Shattock RJ; Le Grand R
Mucosal Immunol; 2014 Jan; 7(1):46-56. PubMed ID: 23591718
[TBL] [Abstract][Full Text] [Related]
6. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.
Strasser R; Stadlmann J; Schähs M; Stiegler G; Quendler H; Mach L; Glössl J; Weterings K; Pabst M; Steinkellner H
Plant Biotechnol J; 2008 May; 6(4):392-402. PubMed ID: 18346095
[TBL] [Abstract][Full Text] [Related]
7. Divergent Requirement of Fc-Fcγ Receptor Interactions for
Wang S; Ren H; Jiang W; Chen H; Hu H; Chen Z; Zhou P
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331095
[TBL] [Abstract][Full Text] [Related]
8. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
[TBL] [Abstract][Full Text] [Related]
9. Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41.
Perez LG; Costa MR; Todd CA; Haynes BF; Montefiori DC
J Virol; 2009 Aug; 83(15):7397-410. PubMed ID: 19458010
[TBL] [Abstract][Full Text] [Related]
10. Identification of Fc Gamma Receptor Glycoforms That Produce Differential Binding Kinetics for Rituximab.
Hayes JM; Frostell A; Karlsson R; Müller S; Martín SM; Pauers M; Reuss F; Cosgrave EF; Anneren C; Davey GP; Rudd PM
Mol Cell Proteomics; 2017 Oct; 16(10):1770-1788. PubMed ID: 28576848
[TBL] [Abstract][Full Text] [Related]
11. Chemoenzymatic synthesis and Fcγ receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcγIIIa receptor.
Zou G; Ochiai H; Huang W; Yang Q; Li C; Wang LX
J Am Chem Soc; 2011 Nov; 133(46):18975-91. PubMed ID: 22004528
[TBL] [Abstract][Full Text] [Related]
12. Engineering the interactions between a plant-produced HIV antibody and human Fc receptors.
Stelter S; Paul MJ; Teh AY; Grandits M; Altmann F; Vanier J; Bardor M; Castilho A; Allen RL; Ma JK
Plant Biotechnol J; 2020 Feb; 18(2):402-414. PubMed ID: 31301102
[TBL] [Abstract][Full Text] [Related]
13. Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors.
Loyau J; Malinge P; Daubeuf B; Shang L; Elson G; Kosco-Vilbois M; Fischer N; Rousseau F
MAbs; 2014; 6(6):1621-30. PubMed ID: 25484053
[TBL] [Abstract][Full Text] [Related]
14. Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile.
Strasser R; Castilho A; Stadlmann J; Kunert R; Quendler H; Gattinger P; Jez J; Rademacher T; Altmann F; Mach L; Steinkellner H
J Biol Chem; 2009 Jul; 284(31):20479-85. PubMed ID: 19478090
[TBL] [Abstract][Full Text] [Related]
15. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose.
Ferrara C; Grau S; Jäger C; Sondermann P; Brünker P; Waldhauer I; Hennig M; Ruf A; Rufer AC; Stihle M; Umaña P; Benz J
Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12669-74. PubMed ID: 21768335
[TBL] [Abstract][Full Text] [Related]
16. Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa.
Ahmed AA; Keremane SR; Vielmetter J; Bjorkman PJ
J Struct Biol; 2016 Apr; 194(1):78-89. PubMed ID: 26850169
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected Cells.
Anand SP; Ding S; Tolbert WD; Prévost J; Richard J; Gil HM; Gendron-Lepage G; Cheung WF; Wang H; Pastora R; Saxena H; Wakarchuk W; Medjahed H; Wines BD; Hogarth M; Shaw GM; Martin MA; Burton DR; Hangartner L; Evans DT; Pazgier M; Cossar D; McLean MD; Finzi A
J Virol; 2021 Aug; 95(18):e0079621. PubMed ID: 34232070
[TBL] [Abstract][Full Text] [Related]
18. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
[TBL] [Abstract][Full Text] [Related]
19. Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions.
Hayes JM; Frostell A; Cosgrave EF; Struwe WB; Potter O; Davey GP; Karlsson R; Anneren C; Rudd PM
J Proteome Res; 2014 Dec; 13(12):5471-85. PubMed ID: 25345863
[TBL] [Abstract][Full Text] [Related]
20. A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques.
Moldt B; Shibata-Koyama M; Rakasz EG; Schultz N; Kanda Y; Dunlop DC; Finstad SL; Jin C; Landucci G; Alpert MD; Dugast AS; Parren PW; Nimmerjahn F; Evans DT; Alter G; Forthal DN; Schmitz JE; Iida S; Poignard P; Watkins DI; Hessell AJ; Burton DR
J Virol; 2012 Jun; 86(11):6189-96. PubMed ID: 22457527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]